Salmaan Keshavjee, M.D., Ph.D.
Associate Professor of Global Health and Social Medicine
Dr. Keshavjee’s research spans four areas: (1) multi-drug resistant tuberculosis (MDR-TB) treatment and policy; (2) health-sector reform and access to health care and medical technology in transitional societies, with a special focus on countries of the former Soviet Union (Central Asia and the Russian Federation); (3) the role of non-governmental organizations in globalization and the formation of trans-border civil society; and (4) modernity, social institutions, civil society, and health in the Middle East and Central Asia. In addition to being an active clinician, his methodological expertise is in ethnography, participant-observation, and qualitative interview techniques. Dr. Keshavjee has led efforts in Tomsk, Siberia, which is the first systematic effort to treat MDR-TB in the Russian Federation in accordance with international clinical practice standards. Between 2006 and 2008 he led the effort to treat MDR-TB/HIV co-infection in Lesotho, which was the first of its kind in this Sub-Saharan African country.
Dr. Keshavjee is an associate professor in the Department of Global Health and Social Medicine and Department of Medicine at Harvard Medical School. He also serves as a physician in the Division of Global Health Equity at the Brigham and Women’s Hospital. He conducted doctoral research in medical anthropology at Harvard University on the health transition in post-Soviet Tajikistan. He has worked with the Division of Global Health Equity and Partners In Health on the implementation of a multidrug-resistant tuberculosis (MDR-TB) treatment program in Tomsk, Russia. Between 2000 and 2008, Dr. Keshavjee set up a program to treat patients co-infected with HIV and MDR-TB in Lesotho. Between 2007 and 2010, Dr. Keshavjee served as the chair of the Green Light Committee Initiative, a Stop TB Partnership/WHO initiative which helps countries gain access to high-quality second-line anti-TB drugs so they can provide treatment for people with MDR-TB in line with the WHO guidelines, the latest scientific evidence, and country experiences. He is currently a member of the Stop TB Partnership’s MDR-TB Working Group Core Group.
Dr. Keshavjee received his ScM from the Harvard School of Public Health in 1993, his PhD in Anthropology and Middle Eastern Studies from Harvard University in 1998, and his MD from Stanford University in 2001. He completed his clinician-scientist residency in Internal Medicine and a fellowship in Social Medicine at Brigham and Women’s Hospital in 2005. In addition to his appointment with the Department of Global Health and Social Medicine, Dr. Keshavjee serves on the faculty of the Division of Global Health Equity (DGHE) at Brigham and Women’s Hospital (BWH). He is also an attending physician in the Department of Medicine at BWH. He is an affiliate and Steering Committee member at the Harvard Center for Middle Eastern Studies.
Isoniazid-resistant Tuberculosis in Children: A Systematic Review. May 1, 2013. The Pediatric infectious disease journal.
Tuberculosis, drug resistance, and the history of modern medicine. September 6, 2012. The New England journal of medicine.
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. August 28, 2012. PLoS medicine.
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. July 10, 2012. Tuberculosis (Edinburgh, Scotland).
Engaging the private sector to increase tuberculosis case detection: an impact evaluation study. June 14, 2012. The Lancet infectious diseases.
Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence. May 22, 2012. PloS one.
Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome. March 7, 2012. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia. February 23, 2012. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology.
Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience. November 24, 2011. Bulletin of the World Health Organization.
Time for zero deaths from tuberculosis. October 22, 2011. Lancet.
Programmatic management of multidrug-resistant tuberculosis: models from three countries. June 8, 2011. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
Rational use of moxifloxacin for tuberculosis treatment. April 1, 2011. The Lancet infectious diseases.
Picking up the pace--scale-up of MDR tuberculosis treatment programs. November 4, 2010. The New England journal of medicine.
Time for a bold new vision at the Stop TB Partnership. October 16, 2010. Lancet.
Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment. April 22, 2010. American journal of respiratory and critical care medicine.
Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. September 25, 2009. PloS one.
Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. August 22, 2008. Lancet.
Extensively drug-resistant tuberculosis, Lesotho. June 1, 2008. Emerging infectious diseases.
Aviation and the delivery of medical care in remote regions: the Lesotho HIV experience. February 1, 2008. Aviation, space, and environmental medicine.
Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. December 1, 2007. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
Expanding global HIV treatment: case studies from the field. October 22, 2007. Annals of the New York Academy of Sciences.
Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease. October 22, 2007. Annals of the New York Academy of Sciences.
Improved case detection of active tuberculosis associated with an antiretroviral treatment program in Lesotho. October 1, 2007. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
Structural violence and clinical medicine. October 1, 2006. PLoS medicine.
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. April 1, 2006. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
Bleeding babies in Badakhshan. Symbolism, materialism, and the political economy of traditional medicine in post-Soviet Tajikistan. March 1, 2006. Medical anthropology quarterly.
Bleeding babies in Badakhshan: symbolism, materialism, and the political economy of traditional medicine in post-Soviet Tajikistan January 1, 2005. Medical Anthropology Quarterly,(in press).
Using DOTS-Plus to improve DOTS and expand access to effective tuberculosis treatment in Tomsk Oblast, Russia October 29, 2004. IUATLD World Conference on Lung Health, Paris, France.
Treatment of alcoholic individuals with MDR-TB in Tomsk, Russia October 29, 2004. IUATLD World Conference on Lung Health, Paris, France.
Community based treatment of MDR-TB in Tomsk Oblast, Russia: using DOTS-Plus to improve and expand access to DOTS June 26, 2004. IUATLD European Region Meeting, Moscow, Russia.
Medicine and money: the ethical transformation of medical practice. March 1, 2004. Medical education.
The contradictions of a revolving drug fund in post-Soviet Tajikistan: selling medicines to starving patients January 1, 2004. Castro A, Merrill S, editors. Unhealthy health policy: a critical anthropological examination.
Medicine betrayed: hemophilia patients and HIV in the US. October 1, 2001. Social science & medicine (1982).
A doctor’s view of medicine and misery March 7, 2001. MS-JAMA online Link: http://www.ama-assn.org/sci-pubs/msjama/articles/vol_285/no_9/keshavjee.ht .
Disintegrating health services and resurgent tuberculosis in post-Soviet Tajikistan: an example of structural violence. March 1, 2000. JAMA : the journal of the American Medical Association.
Medicines and transitions: the political economy of health and social change in post-Soviet Badakhshan, Tajikistan September 1, 1998. Medicines and transitions: the political economy of health and social change in post-Soviet Badakhshan, Tajikistan.
Medical anthropology: insights into the social, political, and economic determinants of health. October 2, 1996. JAMA : the journal of the American Medical Association.
- Department of Medicine, Brigham and Women’s Hospital
- Partners In Health
Societies of the World 25. Case Studies in Global Health: Biosocial Perspectives (Faculty of Arts and Sciences)
Harvard Medical School
BWH/DGH & Social Medicine
641 Huntington Ave
Boston MA 02115